About
Technology
Issues
FAQ
Links
Official Page
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.